Table 2.
No. | Age | Gender | Symptom duration (months) | WBC (/mm) | CRP (mg/dl) | ESR (mm/h) | PSL dose (mg) |
---|---|---|---|---|---|---|---|
1. | 76 | M | 2 | 6,580 | 5.1 | 61 | 20 |
2. | 82 | M | 1 | 8,750 | 9.82 | 88 | 30* |
3. | 76 | M | 2 | 6,690 | 0.47 | 4 | 15 |
* This patient did not respond to PSL probably because of paraneoplastic (prostate cancer) factor-induced disease
PSL predonisolone